Thu: Opko keeps TA 25 at record high

Today's most heavily traded stock Teva fell, but a surge in another healthcare stock, Opko Health, left the Tel Aviv 25 Index slightly higher today and 2.2% up on the week.

The Tel Aviv Stock Exchange (TASE) was flat today. The Tel Aviv 25 Index edged up 0.04% to 1,344.85 points, the Tel Aviv 100 Index edged down 0.04% to 1,212.90 points, and the BlueTech 50 Index rose 0.77% to 326.53 points. Turnover was NIS 1.18 billion.

The TASE was flat today, in line with mixed sessions on European markets and despite gains at the opening on Wall Street. The Tel Aviv 25 Index rose 2.2% for the week, to set a new record, and has risen 13.4% since the beginning of the year.

In the foreign currency market, the Bank of Israel set the shekel-dollar representative exchange rate at NIS 3.569/$, up 0.71% on yesterday's rate, and set the shekel-euro representative exchange rate at NIS 4.806/€, up 0.22%.

In the bond market, long-term Shahar unlinked shekel government bonds and long term Galil CPI-linked government bonds rose fell. The corporate bond benchmark Tel-Bond 20 Index fell 0.16%.

In the stock market, Opko Health Inc. (NYSE: OPK; TASE: OPK) rose 11.8%, for the biggest gain among Tel Aviv 25 shares, while Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) fell 0.2 on the day's biggest turnover of NIS 109.8 million.

Bezeq Israeli Telecommunication Co. Ltd. (TASE: BEZQ) fell 4.3% for the biggest loss among Tel Aviv 25 shares.

Elsewhere in the market, Evogene Ltd. (NYSE: EVGN; TASE:EVGN) fell 3.5%, following its offering on the New York Stock Exchange, and Ceragon Networks Ltd. (Nasdaq: CRNT; TASE:CRNT) corrected upwards 2%, after pricing its secondary offering on Nasdaq. Kamada Ltd. (Nasdaq: KMDA); TASE: KMDA) rose 4.5%, after announcing that it will be included on the MSCI Global Small Cap Index next week.

Africa-Israel Investments Ltd. (TASE:AFIL) fell 7%, after bondholders rejected its request to amend the terms of its deed of bonds. Elad Global Ltd. (TASE: ELGL) rose 3.1%, after buying properties in metropolitan Atlanta for $56 million.

Small-Cap Glycominds Ltd. (TASE: GLCM) fell 8.2%, after announcing the cancellation of a deal.

Published by Globes [online], Israel business news - www.globes-online.com - on November 21, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018